Effect of non-pharmaceutical interventions to contain COVID-19 in China
Top Cited Papers
- 4 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 585 (7825), 410-413
- https://doi.org/10.1038/s41586-020-2293-x
Abstract
On 11 March 2020, the World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) a pandemic1. The strategies based on non-pharmaceutical interventions that were used to contain the outbreak in China appear to be effective2, but quantitative research is still needed to assess the efficacy of non-pharmaceutical interventions and their timings3. Here, using epidemiological data on COVID-19 and anonymized data on human movement4,5, we develop a modelling framework that uses daily travel networks to simulate different outbreak and intervention scenarios across China. We estimate that there were a total of 114,325 cases of COVID-19 (interquartile range 76,776–164,576) in mainland China as of 29 February 2020. Without non-pharmaceutical interventions, we predict that the number of cases would have been 67-fold higher (interquartile range 44–94-fold) by 29 February 2020, and we find that the effectiveness of different interventions varied. We estimate that early detection and isolation of cases prevented more infections than did travel restrictions and contact reductions, but that a combination of non-pharmaceutical interventions achieved the strongest and most rapid effect. According to our model, the lifting of travel restrictions from 17 February 2020 does not lead to an increase in cases across China if social distancing interventions can be maintained, even at a limited level of an on average 25% reduction in contact between individuals that continues until late April. These findings improve our understanding of the effects of non-pharmaceutical interventions on COVID-19, and will inform response efforts across the world.This publication has 19 references indexed in Scilit:
- Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental MeasuresEmerging Infectious Diseases, 2020
- Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-Social Distancing MeasuresEmerging Infectious Diseases, 2020
- Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—International Travel-Related MeasuresEmerging Infectious Diseases, 2020
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaThe New England Journal of Medicine, 2020
- The lockdown of Hubei Province causing different transmission dynamics of the novel coronavirus (2019-nCoV) in Wuhan and BeijingPublished by Cold Spring Harbor Laboratory ,2020
- Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)Eurosurveillance, 2020
- Assessing spread risk of Wuhan novel coronavirus within and beyond China, January-April 2020: a travel network-based modelling studyPublished by Cold Spring Harbor Laboratory ,2020
- Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling studyThe Lancet, 2020
- Measuring mobility, disease connectivity and individual risk: a review of using mobile phone data and mHealth for travel medicineJournal of Travel Medicine, 2019
- Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictusNature Microbiology, 2019